$CYTH
Cyclo Therapeutics, Inc.

2019 Q3 Form 10-Q Financial Statement

#000143774919022919 Filed on November 14, 2019

View on sec.gov

Income Statement

Concept 2019 Q3 2018 Q3 2018 Q2
Revenue $285.9K $224.5K $349.4K
YoY Change 27.37% -6.91% -33.2%
Cost Of Revenue $25.97K $13.05K $54.04K
YoY Change 99.06% -33.64% -31.61%
Gross Profit $259.9K $211.4K $295.4K
YoY Change 22.94% -4.54% -33.48%
Gross Profit Margin 90.92% 94.19% 84.53%
Selling, General & Admin $940.0K $510.0K $740.0K
YoY Change 84.31% -1.92% 0.0%
% of Gross Profit 361.62% 241.21% 250.53%
Research & Development $941.5K $485.7K $844.4K
YoY Change 93.85% 43.4% 60.23%
% of Gross Profit 362.21% 229.73% 285.87%
Depreciation & Amortization $0.00 $0.00 $10.00K
YoY Change -100.0%
% of Gross Profit 0.0% 0.0% 3.39%
Operating Expenses $941.5K $485.7K $844.4K
YoY Change 93.85% 43.4% 60.23%
Operating Profit -$1.629M -$789.8K -$1.295M
YoY Change 106.22% 24.0% 55.83%
Interest Expense $0.00 $0.00 $10.00K
YoY Change
% of Operating Profit
Other Income/Expense, Net $2.451K $5.511K
YoY Change -22.17% 78.7%
Pretax Income -$1.625M -$787.3K -$1.289M
YoY Change 106.44% 24.23% 55.75%
Income Tax
% Of Pretax Income
Net Earnings -$1.625M -$787.3K -$1.289M
YoY Change 106.44% 24.23% 55.75%
Net Earnings / Revenue -568.47% -350.72% -368.97%
Basic Earnings Per Share
Diluted Earnings Per Share -$1.347M -$908.0K -$1.633M
COMMON SHARES
Basic Shares Outstanding 121.0M
Diluted Shares Outstanding

Balance Sheet

Concept 2019 Q3 2018 Q3 2018 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $4.990M $1.120M $1.540M
YoY Change 345.54% -16.42% 15.79%
Cash & Equivalents $4.994M $1.122M $1.541M
Short-Term Investments
Other Short-Term Assets $240.0K $44.82K $44.82K
YoY Change 435.44% 121.79% 3.95%
Inventory $384.1K $436.6K $407.6K
Prepaid Expenses
Receivables $35.74K $71.27K $91.43K
Other Receivables $30.00K $40.00K $40.00K
Total Short-Term Assets $5.690M $1.711M $2.121M
YoY Change 232.55% -12.94% 6.95%
LONG-TERM ASSETS
Property, Plant & Equipment $15.63K $19.82K $22.34K
YoY Change -21.11% -27.21% -15.34%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $172.6K $160.2K $171.7K
YoY Change 7.79% -21.71% -19.16%
TOTAL ASSETS
Total Short-Term Assets $5.690M $1.711M $2.121M
Total Long-Term Assets $172.6K $160.2K $171.7K
Total Assets $5.862M $1.871M $2.292M
YoY Change 213.31% -13.77% 4.43%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $2.320M $1.650M $1.290M
YoY Change 40.61% 200.0% 126.32%
Accrued Expenses $10.00K
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $2.337M $1.650M $1.290M
YoY Change 41.62% 46.0% 126.32%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $40.00K
YoY Change
Total Long-Term Liabilities $40.00K $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $2.337M $1.650M $1.290M
Total Long-Term Liabilities $40.00K $0.00 $0.00
Total Liabilities $2.380M $1.650M $1.290M
YoY Change 44.24% 46.02% 126.32%
SHAREHOLDERS EQUITY
Retained Earnings -$22.49M -$16.22M -$15.43M
YoY Change 38.61% 35.77% 36.41%
Common Stock $12.11K $8.723K $8.723K
YoY Change 38.83% 19.51% 19.71%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $3.483M $216.1K $1.003M
YoY Change
Total Liabilities & Shareholders Equity $5.862M $1.871M $2.292M
YoY Change 213.31% -13.77% 4.43%

Cashflow Statement

Concept 2019 Q3 2018 Q3 2018 Q2
OPERATING ACTIVITIES
Net Income -$1.625M -$787.3K -$1.289M
YoY Change 106.44% 24.23% 55.75%
Depreciation, Depletion And Amortization $0.00 $0.00 $10.00K
YoY Change -100.0%
Cash From Operating Activities -$1.620M -$420.0K -$970.0K
YoY Change 285.71% -27.59% 203.13%
INVESTING ACTIVITIES
Capital Expenditures $0.00 $0.00 $0.00
YoY Change -100.0%
Acquisitions
YoY Change
Other Investing Activities $10.00K $10.00K $20.00K
YoY Change 0.0% 0.0% 100.0%
Cash From Investing Activities $10.00K $10.00K $20.00K
YoY Change 0.0% 100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 0.000 0.000 1.890M
YoY Change -100.0%
NET CHANGE
Cash From Operating Activities -1.620M -420.0K -970.0K
Cash From Investing Activities 10.00K 10.00K 20.00K
Cash From Financing Activities 0.000 0.000 1.890M
Net Change In Cash -1.610M -410.0K 940.0K
YoY Change 292.68% -4200.0% -403.23%
FREE CASH FLOW
Cash From Operating Activities -$1.620M -$420.0K -$970.0K
Capital Expenditures $0.00 $0.00 $0.00
Free Cash Flow -$1.620M -$420.0K -$970.0K
YoY Change 285.71% -26.32% 203.13%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2019Q1 ctdh Equity Impact Of Cash Received From Stock Subscription
EquityImpactOfCashReceivedFromStockSubscription
130062
CY2019Q3 ctdh Freight And Shipping
FreightAndShipping
1527
CY2018Q3 ctdh Freight And Shipping
FreightAndShipping
1036
ctdh Freight And Shipping
FreightAndShipping
3977
ctdh Freight And Shipping
FreightAndShipping
4561
CY2016Q1 ctdh Mortgage Loans On Real Estate Monthly Payment
MortgageLoansOnRealEstateMonthlyPayment
3653
CY2019Q3 ctdh Operating Lease Right Of Usse Asset Amortization
OperatingLeaseRightOfUsseAssetAmortization
12754
CY2019Q3 ctdh Prepaid Expenses Current Excluding Prepaid Insurance
PrepaidExpensesCurrentExcludingPrepaidInsurance
217395
CY2018Q4 ctdh Prepaid Expenses Current Excluding Prepaid Insurance
PrepaidExpensesCurrentExcludingPrepaidInsurance
ctdh Proceeds From Collection Of Stock Subscription
ProceedsFromCollectionOfStockSubscription
130062
ctdh Proceeds From Collection Of Stock Subscription
ProceedsFromCollectionOfStockSubscription
ctdh Proceeds From Sale Of Common Stock And Warrants Net Of Issue Costs
ProceedsFromSaleOfCommonStockAndWarrantsNetOfIssueCosts
6989600
ctdh Proceeds From Sale Of Common Stock And Warrants Net Of Issue Costs
ProceedsFromSaleOfCommonStockAndWarrantsNetOfIssueCosts
1960000
CY2019Q3 ctdh Repairs And Maintenance
RepairsAndMaintenance
1232
CY2018Q3 ctdh Repairs And Maintenance
RepairsAndMaintenance
1203
ctdh Repairs And Maintenance
RepairsAndMaintenance
4215
ctdh Repairs And Maintenance
RepairsAndMaintenance
2474
ctdh Sharebased Compensation Employees
SharebasedCompensationEmployees
104100
ctdh Sharebased Compensation Employees
SharebasedCompensationEmployees
11700
ctdh Sharebased Compensation Nonemployees
SharebasedCompensationNonemployees
55280
ctdh Sharebased Compensation Nonemployees
SharebasedCompensationNonemployees
38610
CY2016Q1 srt Mortgage Loans On Real Estate Face Amount Of Mortgages
MortgageLoansOnRealEstateFaceAmountOfMortgages
265000
CY2016Q1 srt Mortgage Loans On Real Estate Interest Rate
MortgageLoansOnRealEstateInterestRate
0.0425
CY2019Q3 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
2322516
CY2018Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
1925332
CY2019Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
35742
CY2018Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
80044
CY2019Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
25956355
CY2018Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
18701211
us-gaap Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities
AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities
528040
us-gaap Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities
AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities
755694
CY2019Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
97250
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
159380
CY2018Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
22360
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
50310
CY2019Q3 us-gaap Assets
Assets
5862239
CY2018Q4 us-gaap Assets
Assets
2917856
CY2019Q3 us-gaap Assets Current
AssetsCurrent
5689606
CY2018Q4 us-gaap Assets Current
AssetsCurrent
2769611
us-gaap Capital Lease Obligations Incurred
CapitalLeaseObligationsIncurred
56476
us-gaap Capital Lease Obligations Incurred
CapitalLeaseObligationsIncurred
CY2019Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
4994215
CY2018Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2217412
CY2017Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1270973
CY2018Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1122340
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
2776803
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-148633
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.05
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.04
CY2018Q3 us-gaap Investment Income Nonoperating
InvestmentIncomeNonoperating
2451
CY2019Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2018Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2019Q3 us-gaap Common Stock Share Subscribed But Unissued Subscriptions Receivable
CommonStockShareSubscribedButUnissuedSubscriptionsReceivable
CY2018Q4 us-gaap Common Stock Share Subscribed But Unissued Subscriptions Receivable
CommonStockShareSubscribedButUnissuedSubscriptionsReceivable
130062
CY2019Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000
CY2018Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000
CY2019Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
121114990
CY2018Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
90759324
CY2019Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
121114990
CY2018Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
90759324
CY2019Q3 us-gaap Common Stock Value
CommonStockValue
12110
CY2018Q4 us-gaap Common Stock Value
CommonStockValue
9075
CY2019Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
25971
CY2018Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
13047
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
62830
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
90759
CY2019Q3 us-gaap Costs And Expenses
CostsAndExpenses
1914539
CY2018Q3 us-gaap Costs And Expenses
CostsAndExpenses
1014232
us-gaap Costs And Expenses
CostsAndExpenses
5686534
us-gaap Costs And Expenses
CostsAndExpenses
3670832
us-gaap Depreciation
Depreciation
4261
us-gaap Depreciation
Depreciation
7553
CY2019Q3 us-gaap Depreciation Nonproduction
DepreciationNonproduction
1292
CY2018Q3 us-gaap Depreciation Nonproduction
DepreciationNonproduction
2527
us-gaap Depreciation Nonproduction
DepreciationNonproduction
4261
us-gaap Depreciation Nonproduction
DepreciationNonproduction
7553
us-gaap Investment Income Nonoperating
InvestmentIncomeNonoperating
9181
us-gaap Investment Income Nonoperating
InvestmentIncomeNonoperating
9394
us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
268579
us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
CY2019Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.01
CY2018Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.01
CY2019Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-1625341
CY2018Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-787301
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-4897518
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-2889474
CY2019Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
CY2018Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
CY2019Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
5862239
CY2018Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2917856
CY2019Q3 us-gaap Liabilities Current
LiabilitiesCurrent
2336698
CY2018Q4 us-gaap Liabilities Current
LiabilitiesCurrent
1925332
us-gaap Income Taxes Paid
IncomeTaxesPaid
us-gaap Income Taxes Paid
IncomeTaxesPaid
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
237804
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
661582
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-44302
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
14410
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-32420
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-34636
us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
2519
us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
-16023
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
-1208
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
217395
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
us-gaap Interest Paid Net
InterestPaidNet
us-gaap Interest Paid Net
InterestPaidNet
CY2019Q3 us-gaap Inventory Net
InventoryNet
384111
CY2018Q4 us-gaap Inventory Net
InventoryNet
416531
CY2018Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
39700
CY2019Q3 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
39700
CY2019Q3 us-gaap Investment Income Nonoperating
InvestmentIncomeNonoperating
3284
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
25147
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-4369478
CY2019Q3 us-gaap Long Term Accounts Notes And Loans Receivable Net Noncurrent
LongTermAccountsNotesAndLoansReceivableNetNoncurrent
101731
CY2018Q4 us-gaap Long Term Accounts Notes And Loans Receivable Net Noncurrent
LongTermAccountsNotesAndLoansReceivableNetNoncurrent
129674
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
7119662
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1960000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
26619
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-2133780
us-gaap Net Income Loss
NetIncomeLoss
-4897518
us-gaap Net Income Loss
NetIncomeLoss
-2889474
CY2018Q1 us-gaap Net Income Loss
NetIncomeLoss
-812944
CY2018Q2 us-gaap Net Income Loss
NetIncomeLoss
-1289229
CY2018Q3 us-gaap Net Income Loss
NetIncomeLoss
-787301
CY2019Q1 us-gaap Net Income Loss
NetIncomeLoss
-1904166
CY2019Q2 us-gaap Net Income Loss
NetIncomeLoss
-1368011
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
-1625341
CY2019Q3 us-gaap Noninterest Expense Directors Fees
NoninterestExpenseDirectorsFees
37008
CY2018Q3 us-gaap Noninterest Expense Directors Fees
NoninterestExpenseDirectorsFees
26549
us-gaap Noninterest Expense Directors Fees
NoninterestExpenseDirectorsFees
101704
us-gaap Noninterest Expense Directors Fees
NoninterestExpenseDirectorsFees
69565
CY2019Q3 us-gaap Notes And Loans Receivable Net Current
NotesAndLoansReceivableNetCurrent
37439
CY2018Q4 us-gaap Notes And Loans Receivable Net Current
NotesAndLoansReceivableNetCurrent
37439
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
CY2019Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-1628625
CY2018Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-789752
us-gaap Operating Income Loss
OperatingIncomeLoss
-4906699
us-gaap Operating Income Loss
OperatingIncomeLoss
-2898868
CY2019Q3 us-gaap Operating Lease Expense
OperatingLeaseExpense
5466
us-gaap Operating Lease Expense
OperatingLeaseExpense
16842
CY2019Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
14182
CY2018Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
CY2019Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
42294
CY2018Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
CY2019Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
55268
CY2018Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
CY2019Q3 us-gaap Other Selling General And Administrative Expense
OtherSellingGeneralAndAdministrativeExpense
233555
CY2018Q3 us-gaap Other Selling General And Administrative Expense
OtherSellingGeneralAndAdministrativeExpense
57227
us-gaap Other Selling General And Administrative Expense
OtherSellingGeneralAndAdministrativeExpense
583692
us-gaap Other Selling General And Administrative Expense
OtherSellingGeneralAndAdministrativeExpense
223076
us-gaap Payments For Proceeds From Loans Receivable
PaymentsForProceedsFromLoansReceivable
-27943
us-gaap Payments For Proceeds From Loans Receivable
PaymentsForProceedsFromLoansReceivable
-26781
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1324
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1634
CY2019Q3 us-gaap Preferred Stock Value
PreferredStockValue
CY2018Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2019Q3 us-gaap Prepaid Insurance
PrepaidInsurance
20704
CY2019Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2018Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2019Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2018Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2019Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2018Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2018Q4 us-gaap Prepaid Insurance
PrepaidInsurance
18185
CY2018Q1 us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
74983
CY2016Q1 us-gaap Proceeds From Sale Of Property Held For Sale
ProceedsFromSaleOfPropertyHeldForSale
10000
CY2019Q3 us-gaap Professional Fees
ProfessionalFees
151749
CY2018Q3 us-gaap Professional Fees
ProfessionalFees
132308
us-gaap Professional Fees
ProfessionalFees
613000
us-gaap Professional Fees
ProfessionalFees
663592
CY2019Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
15634
CY2018Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
18571
CY2019Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
941539
CY2018Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
485715
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3071113
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1739289
CY2019Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-22485218
CY2018Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-17587700
CY2019Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
285914
CY2018Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
224480
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
779835
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
771964
CY2019Q3 us-gaap Salaries And Wages
SalariesAndWages
520666
CY2018Q3 us-gaap Salaries And Wages
SalariesAndWages
294620
us-gaap Salaries And Wages
SalariesAndWages
1241742
us-gaap Salaries And Wages
SalariesAndWages
859963
CY2019Q3 us-gaap Stock Granted During Period Value Sharebased Compensation Gross
StockGrantedDuringPeriodValueSharebasedCompensationGross
268579
CY2019Q3 us-gaap Stock Issued During Period Shares Issued For Services
StockIssuedDuringPeriodSharesIssuedForServices
585666
CY2019Q3 us-gaap Stock Issued During Period Shares Share Based Compensation Gross
StockIssuedDuringPeriodSharesShareBasedCompensationGross
450000
CY2018Q2 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
CY2019Q3 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
268579
CY2018Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
1960000
CY2019Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
6989600
CY2019Q3 us-gaap Stock Issued During Period Value Share Based Compensation Gross
StockIssuedDuringPeriodValueShareBasedCompensationGross
87750
CY2019Q3 us-gaap Stockholders Equity
StockholdersEquity
3483247
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
992524
CY2017Q4 us-gaap Stockholders Equity
StockholdersEquity
1145618
CY2018Q1 us-gaap Stockholders Equity
StockholdersEquity
332674
CY2018Q2 us-gaap Stockholders Equity
StockholdersEquity
1003445
CY2018Q3 us-gaap Stockholders Equity
StockholdersEquity
216144
CY2019Q1 us-gaap Stockholders Equity
StockholdersEquity
-781580
CY2019Q2 us-gaap Stockholders Equity
StockholdersEquity
4840009
us-gaap Use Of Estimates
UseOfEstimates
<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">(n) USE OF ESTIMATES&#x2013;&#x2013;The preparation of consolidated financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes. Although management bases its estimates on historical experience and assumptions that are believed to be reasonable under the circumstances, actual results could significantly differ from these estimates.</div></div></div></div></div></div></div></div></div>
CY2019Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
121086101
CY2018Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
87239361
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
104286287
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
79697435

Files In Submission

Name View Source Status
0001437749-19-022919-index-headers.html Edgar Link pending
0001437749-19-022919-index.html Edgar Link pending
0001437749-19-022919.txt Edgar Link pending
0001437749-19-022919-xbrl.zip Edgar Link pending
ctdh-20190930.xml Edgar Link completed
ctdh-20190930.xsd Edgar Link pending
ctdh-20190930_cal.xml Edgar Link unprocessable
ctdh-20190930_def.xml Edgar Link unprocessable
ctdh-20190930_lab.xml Edgar Link unprocessable
ctdh-20190930_pre.xml Edgar Link unprocessable
ctdh20190930_10q.htm Edgar Link pending
ex_164619.htm Edgar Link pending
ex_164620.htm Edgar Link pending
ex_164621.htm Edgar Link pending
ex_164622.htm Edgar Link pending
ex_164759.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending